Page last updated: 2024-08-26

tretazicar and vitamin k 3

tretazicar has been researched along with vitamin k 3 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Celli, CM; Jaiswal, AK; Knox, R; Tran, N	1
Daff, S; Guise, CP; Hyde, EI; Jaberipour, M; Jarrom, D; Searle, PF; White, SA	1

Other Studies

2 other study(ies) available for tretazicar and vitamin k 3

Article	Year
NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs. Biochemical pharmacology, 2006, Jul-28, Volume: 72, Issue:3 Topics: Animals; Antineoplastic Agents; Aziridines; Benzopyrenes; Biotransformation; Cell Survival; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Cross-Linking Reagents; DNA, Complementary; Dose-Response Relationship, Drug; Hydroquinones; Indolequinones; Keratinocytes; Mice; Mice, Knockout; Mitomycin; Mitomycins; Quinone Reductases; Quinones; Transfection; Vitamin K 3	2006
Steady-state and stopped-flow kinetic studies of three Escherichia coli NfsB mutants with enhanced activity for the prodrug CB1954. Biochemistry, 2009, Aug-18, Volume: 48, Issue:32 Topics: Anti-Infective Agents; Antineoplastic Agents; Aziridines; Escherichia coli; Escherichia coli Proteins; Models, Molecular; Molecular Structure; Mutation; Nitrofurazone; Nitroreductases; Prodrugs; Protein Structure, Tertiary; Vitamin K 3; Vitamins	2009

Article

Year

NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.

Biochemical pharmacology, 2006, Jul-28, Volume: 72, Issue:3

Topics: Animals; Antineoplastic Agents; Aziridines; Benzopyrenes; Biotransformation; Cell Survival; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Cross-Linking Reagents; DNA, Complementary; Dose-Response Relationship, Drug; Hydroquinones; Indolequinones; Keratinocytes; Mice; Mice, Knockout; Mitomycin; Mitomycins; Quinone Reductases; Quinones; Transfection; Vitamin K 3

2006

Steady-state and stopped-flow kinetic studies of three Escherichia coli NfsB mutants with enhanced activity for the prodrug CB1954.

Biochemistry, 2009, Aug-18, Volume: 48, Issue:32

Topics: Anti-Infective Agents; Antineoplastic Agents; Aziridines; Escherichia coli; Escherichia coli Proteins; Models, Molecular; Molecular Structure; Mutation; Nitrofurazone; Nitroreductases; Prodrugs; Protein Structure, Tertiary; Vitamin K 3; Vitamins

2009